SLU-PP-915
The first orally-active pan-ERR agonist, raised exercise capacity in mice even when…
The read
What people observed
Every report answers on a 1–5 scale. This is the whole distribution, never an average pretending to be one number, though the average is beside it.
1 · no effect
1
2 · barely
0
3 · modest
2
4 · clearly worked
1
5 · textbook
1
3.2/5
Average reported outcome
80%
Would run it again
5
Reports filed · very early
What it did, and what else showed up
Counts across this compound's reports, never an average. One report can select several answers.
Reported positive outcomes
better sleep
1
fat loss
1
libido
1
injury healing
1
better bloodwork
1
Reported side effects
Kept separate from positive outcomes on purpose.
fatigue
2
none / clean
1
headache
1
sleep disruption
1
mood / anxiety
1
appetite change
1
How it was run
What people brought it in for, and how long they stayed on it. Intent, not a result or a treatment claim.
What people were researching
blood sugar / metabolic
2
focus / cognition
1
cardiovascular / blood pressure
1
How long they ran it
1 wk
2
6 wk
1
16 wk+
2
Anecdote, never medical advice.
These are anonymous personal reports on an experimental research compound, not clinical evidence, and they never set the grade. Talk to a licensed clinician before you start, stop, or change a dose.